Obagi Therapeutic Moisturizer Review

There is a line on the Obagi product page that says this moisturiser is not available to ship to California or Maryland, with no explanation, and the explanation is on the ingredient list. The CLENZIderm M.D. Therapeutic Moisturizer is preserved with five parabens, and two of them, propylparaben and isobutylparaben, are now restricted in cosmetics sold in those two states under laws passed in the early 2020s. Obagi's response was not to reformulate but to stop shipping there. That decision says something about the product: it is a formula from 2007, the year the CLENZIderm system launched as a three-step, dermatology-office answer to acne, and in the nineteen years since, the brand has evidently judged that it works well enough to leave alone. The interesting question is whether that judgement is right, and, mostly, it is.

The formula is short and does one thing. Glycerin is declared as the active ingredient at twenty percent under the FDA's skin-protectant monograph, which is four or five times what a typical moisturiser carries and enough to make a legal claim about protecting and relieving dry skin. Around it is water, a silicone system of cyclopentasiloxane, dimethicone, a dimethicone elastomer, cetyl dimethicone and a silicone emulsifier, a modified corn starch for slip and oil absorption, an acrylate polymer and triethanolamine for structure, allantoin for soothing, and then the preservatives, phenoxyethanol plus the five parabens. No oils, no waxes, no fatty esters, no fragrance, no alcohol. It is a humectant held in a breathable occlusive film, which is the textbook construction of a moisturiser for skin being dried out by a treatment.

That construction is the reason it works, and the science is not controversial. Glycerol is a natural component of the skin's own water-holding system, and topical glycerin at high concentrations has been shown to increase stratum corneum hydration, accelerate barrier recovery after damage and reduce the tightness and scaling that follow irritant exposure; a 2008 review in the British Journal of Dermatology traced its functions from humectancy through barrier repair to desquamation. Dimethicone and the other silicones slow water loss without the comedogenic risk that plant oils carry on acne-prone skin, which is exactly the population this cream is for. Benzoyl peroxide and topical retinoids, the drugs in the rest of the CLENZIderm system and in most acne routines, dry and inflame the barrier, and the single biggest reason patients abandon them is that discomfort. A cream that removes the discomfort keeps the patient on the drug that works.

In use, it does what the design predicts. A light white cream with a primer-like glide goes on thin, sets in a minute to a satin finish, and takes the sting out of freshly treated skin; peeling settles within the first week, and oily skin does not break out from it, which is the single point on which its long threads of reviews at clinical retailers agree most firmly. The complaints are just as consistent: a faint sheen by midday, which is the glycerin, and not enough richness for truly dry winter skin, because there is no lipid in it at all, a gap that matters most for patients on isotretinoin or a strong retinoid whose skin needs fats replaced rather than water held. The two dozen reviews on Obagi's own site, at 4.6 stars, are a small sample; the years of feedback at LovelySkin and Amazon are the real record, and they describe people who have kept the same white pump bottle on the shelf for a decade.

The things to hold against it are two. The preservative system is the obvious one, not because parabens are dangerous at cosmetic levels, where their safety record is long and the alarm around them has never been matched by evidence, but because five of them in one product is a 2007 choice that a reformulation would have trimmed to one or two modern preservatives, and because the choice now excludes customers in two states. The other is the price. Fifty dollars for 1.7 ounces of glycerin and dimethicone is a physician-channel figure; the same construction exists in drugstore moisturisers at a fifth of the cost, and the CLENZIderm cream's real advantage is that it was built to the exact brief, oil-free, fragrance-free, twenty percent humectant, silicone film, rather than adapted to it.

So the verdict is straightforward. For anyone on benzoyl peroxide, adapalene or tretinoin whose skin is fighting the treatment, this is a well-made, reliable companion cream that will not clog, will not sting and will keep the routine going, and if a dermatologist has dispensed the CLENZIderm kit it belongs in it. For anyone without an acne treatment to support, it is an overpriced glycerin cream with an outdated preservative system and no lipids, and a modern barrier moisturiser would do more for less. Obagi has left it alone for nineteen years because it works; a reformulation that kept the twenty percent glycerin and dropped four parabens would let it work everywhere.